Pontifax
Feb 22, 2018
The Business Cocktail : Latest Pharma deals
Ionis pharmaceuticals recently licensed-out its antisense drug to AstraZeneca in deal total worth up to USD 330 million Ionis Pharmaceuticals has recently licensed-out an antisense drug to AstraZeneca, bagging a payment of USD 30 million as an upfront licensing fee. AstraZeneca will now be taking care of the develo...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
